Sci Pharmtech (TPE:4119) Total Liabilities: NT$1,492 Mil (As of Dec. 2025)


TPE:4119 Sci Pharmtech Inc TPE:4119
67 GF Score
Price NT$44.75
GF Value NT$96.74
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Sci Pharmtech Total Liabilities?

Sci Pharmtech TPE:4119 -1.32% 67 Total Liabilities is NT$1,492 Mil as of Dec. 2025. GuruFocus rates TPE:4119 with a GF Score™ of 67/100 and a GF Value™ of NT$96.74 (Possible Value Trap). The stock has 9 warning signs investors should review.

Sci Pharmtech's Total Liabilities for the quarter that ended in Dec. 2025 was NT$1,492 Mil.

Sci Pharmtech's quarterly Total Liabilities declined from Jun. 2025 (NT$1,631.74 Mil) to Sep. 2025 (NT$1,481.93 Mil) but then increased from Sep. 2025 (NT$1,481.93 Mil) to Dec. 2025 (NT$1,492.36 Mil).

Sci Pharmtech's annual Total Liabilities increased from Dec. 2023 (NT$1,590.79 Mil) to Dec. 2024 (NT$1,723.85 Mil) but then declined from Dec. 2024 (NT$1,723.85 Mil) to Dec. 2025 (NT$1,492.36 Mil).

Sci Pharmtech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Sci Pharmtech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sci Pharmtech Total Liabilities Chart

Sci Pharmtech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 869.26 1,331.32 1,590.79 1,723.85 1,492.36

Sci Pharmtech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,723.85 1,544.65 1,631.74 1,481.93 1,492.36
TPE:4119
67GF Score
Sci Pharmtech Inc TPE:4119
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sci Pharmtech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sci Pharmtech's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1036.371+(302.851+113.205
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+7.604+32.333)
=1,492

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=6886.846-5394.482
=1,492

Sci Pharmtech's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1036.371+(302.851+113.205
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+7.604+32.333)
=1,492

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=6886.846-5394.482
=1,492

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$1,492 Mil mean?
Sci Pharmtech (TPE:4119) has a Total Liabilities of NT$1,492 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sci Pharmtech and its competitors.
Is Sci Pharmtech's Total Liabilities too high?
Sci Pharmtech's current Total Liabilities is NT$1,492 Mil. Overall, Sci Pharmtech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sci Pharmtech's Total Liabilities compare to ZTS and UTHR?
Sci Pharmtech's Total Liabilities of NT$1,492 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sci Pharmtech and its competitors. Sci Pharmtech's current Total Liabilities is NT$1,492 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sci Pharmtech stock overvalued right now?
Based on GuruFocus' analysis, Sci Pharmtech (TPE:4119) is currently considered Possible Value Trap. The stock's GF Value™ is NT$96.74, compared to a current price of NT$44.75 — trading 53.7% below its estimated fair value. The current Total Liabilities is NT$1,492 Mil. Sci Pharmtech's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Sci Pharmtech (TPE:4119), the current Total Liabilities is NT$1,492 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sci Pharmtech (TPE:4119) Overvalued in 2026?

Based on GuruFocus' analysis, Sci Pharmtech stock appears to be undervalued. The current stock price of NT$44.75 is trading 53.7% below its estimated GF Value™ of NT$96.74. GuruFocus considers Sci Pharmtech to be Possible Value Trap.

Key valuation signals for TPE:4119:

  • Total Liabilities: NT$1,492 Mil
  • GF Value™: NT$96.74 vs. price of NT$44.75 (53.7% below fair value)
  • GF Score™: 67/100 with 9 warning signs

No single metric tells the full story. See the TPE:4119 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sci Pharmtech Business Description

Address No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sales of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, Switzerland, Spain, Belgium, Netherlands, and others.
67GF Score

Get the complete analysis for TPE:4119

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$44.75
Price
NT$96.74
GF Value